SAN DIEGO, Aug. 3, 2010 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its financial results for the second quarter and six months ended June 30, 2010 before the market opens on Thursday, August 12, 2010.
Date: August 12, 2010 Time: 8:30 AM ETListen via Internet: http://www.tearlab.com/us/shareholder.htm/ Schedule this webcast into MS-Outlook calendar (click open when prompted): http://apps.shareholder.com/PNWOutlook/t.aspx?m=43708&k=0016EDAD
Telephone: 877-303-6310For those wishing to listen to a recording of the call via telephone, a replay will be made available as soon as possible after the conclusion of the live call and will remain posted for a period of seven days. To listen to the recording, simply telephone (Toll free) 800-642-1687 or Toll 706-645-9291 and enter reservation #92168732 when prompted. About OccuLogix, Inc. dba TearLab Corporation OccuLogix dba TearLab Corporation ( www.tearlab.com) develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'. TearLab received the CE Mark for its TearLab(TM) Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 20 countries including the US. Forward-Looking Statements